Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe website revision identifier in the footer changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check26 days agoChange DetectedA notice was added announcing NIH website changes and explaining that the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence”.SummaryDifference0.7%

- Check33 days agoChange DetectedThe ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check40 days agoChange DetectedThe site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded a new revision entry v3.7.0 to the study record history. The previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check82 days agoChange DetectedA new revision (v3.6.6) was added to the study's history, replacing the previous revision (v3.6.5) and indicating an update to the record on ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.